Literature DB >> 21987764

The importance of the NP: VP35 ratio in Ebola virus nucleocapsid formation.

Takeshi Noda1, Larissa Kolesnikova, Stephan Becker, Yoshihiro Kawaoka.   

Abstract

Ebola virus VP35 is a cofactor of the viral RNA polymerase complex and, together with NP and VP24, is an essential component for nucleocapsid formation. In the present study, we examined the interactions between VP35 and NP and found that VP35 interacts with helical NP-RNA complexes through the C-terminus of NP. We also found that coexpression of excess VP35 with NP reduced the yields of NP-RNA complexes purified by CsCl gradient ultracentrifugation and inhibited the formation of the NP-induced inclusion bodies that typically form in Ebola virus-infected cells. These findings suggest that the NP to VP35 ratio is important in the Ebola virus replication cycle and advance our knowledge of nucleocapsid morphogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21987764      PMCID: PMC3189984          DOI: 10.1093/infdis/jir310

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  35 in total

1.  The Ebola virus VP35 protein functions as a type I IFN antagonist.

Authors:  C F Basler; X Wang; E Mühlberger; V Volchkov; J Paragas; H D Klenk; A García-Sastre; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

2.  A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding.

Authors:  R N Harty; M E Brown; G Wang; J Huibregtse; F P Hayes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

3.  Vesicular release of ebola virus matrix protein VP40.

Authors:  J Timmins; S Scianimanico; G Schoehn; W Weissenhorn
Journal:  Virology       Date:  2001-04-25       Impact factor: 3.616

4.  Study of the assembly of vesicular stomatitis virus N protein: role of the P protein.

Authors:  T J Green; S Macpherson; S Qiu; J Lebowitz; G W Wertz; M Luo
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

5.  Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP.

Authors:  Takeshi Noda; Hiroshi Sagara; Emiko Suzuki; Ayato Takada; Hiroshi Kida; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

6.  Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation.

Authors:  Michael Weik; Jens Modrof; Hans-Dieter Klenk; Stephan Becker; Elke Mühlberger
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

7.  The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3.

Authors:  Christopher F Basler; Andrea Mikulasova; Luis Martinez-Sobrido; Jason Paragas; Elke Mühlberger; Mike Bray; Hans-Dieter Klenk; Peter Palese; Adolfo García-Sastre
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

8.  The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein.

Authors:  Yue Huang; Ling Xu; Yongnian Sun; Gary J Nabel
Journal:  Mol Cell       Date:  2002-08       Impact factor: 17.970

9.  Characterization of the Ebola virus nucleoprotein-RNA complex.

Authors:  Takeshi Noda; Kyoji Hagiwara; Hiroshi Sagara; Yoshihiro Kawaoka
Journal:  J Gen Virol       Date:  2010-02-17       Impact factor: 3.891

10.  Ebola virus infection inversely correlates with the overall expression levels of promyelocytic leukaemia (PML) protein in cultured cells.

Authors:  Asa Szekely Björndal; Laszlo Szekely; Fredrik Elgh
Journal:  BMC Microbiol       Date:  2003-04-04       Impact factor: 3.605

View more
  19 in total

1.  Structural Insight into Nucleoprotein Conformation Change Chaperoned by VP35 Peptide in Marburg Virus.

Authors:  Baocheng Liu; Shishang Dong; Guobang Li; Wenming Wang; Xiang Liu; Yantong Wang; Cheng Yang; Zihe Rao; Yu Guo
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

2.  The structure of the C-terminal domain of the nucleoprotein from the Bundibugyo strain of the Ebola virus in complex with a pan-specific synthetic Fab.

Authors:  Malwina J Radwańska; Mateusz Jaskółowski; Elena Davydova; Urszula Derewenda; Tsuyoshi Miyake; Daniel A Engel; Anthony A Kossiakoff; Zygmunt S Derewenda
Journal:  Acta Crystallogr D Struct Biol       Date:  2018-06-27       Impact factor: 7.652

3.  Ebola Virus Inclusion Body Formation and RNA Synthesis Are Controlled by a Novel Domain of Nucleoprotein Interacting with VP35.

Authors:  Tsuyoshi Miyake; Charlotte M Farley; Benjamin E Neubauer; Thomas P Beddow; Thomas Hoenen; Daniel A Engel
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

4.  Inclusion bodies are a site of ebolavirus replication.

Authors:  Thomas Hoenen; Reed S Shabman; Allison Groseth; Astrid Herwig; Michaela Weber; Gordian Schudt; Olga Dolnik; Christopher F Basler; Stephan Becker; Heinz Feldmann
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

5.  Phosphorylation of Ebola virus VP30 influences the composition of the viral nucleocapsid complex: impact on viral transcription and replication.

Authors:  Nadine Biedenkopf; Bettina Hartlieb; Thomas Hoenen; Stephan Becker
Journal:  J Biol Chem       Date:  2013-03-14       Impact factor: 5.157

6.  The multifunctional Ebola virus VP40 matrix protein is a promising therapeutic target.

Authors:  Jonathan J Madara; Ziying Han; Gordon Ruthel; Bruce D Freedman; Ronald N Harty
Journal:  Future Virol       Date:  2015-05       Impact factor: 1.831

7.  An Intrinsically Disordered Peptide from Ebola Virus VP35 Controls Viral RNA Synthesis by Modulating Nucleoprotein-RNA Interactions.

Authors:  Daisy W Leung; Dominika Borek; Priya Luthra; Jennifer M Binning; Manu Anantpadma; Gai Liu; Ian B Harvey; Zhaoming Su; Ariel Endlich-Frazier; Juanli Pan; Reed S Shabman; Wah Chiu; Robert A Davey; Zbyszek Otwinowski; Christopher F Basler; Gaya K Amarasinghe
Journal:  Cell Rep       Date:  2015-04-09       Impact factor: 9.423

8.  Assembly of the Ebola Virus Nucleoprotein from a Chaperoned VP35 Complex.

Authors:  Robert N Kirchdoerfer; Dafna M Abelson; Sheng Li; Malcolm R Wood; Erica Ollmann Saphire
Journal:  Cell Rep       Date:  2015-06-25       Impact factor: 9.423

9.  The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals.

Authors:  Martina Trunschke; Dominik Conrad; Sven Enterlein; Judith Olejnik; Kristina Brauburger; Elke Mühlberger
Journal:  Virology       Date:  2013-04-11       Impact factor: 3.616

10.  Dynamic Phosphorylation of VP30 Is Essential for Ebola Virus Life Cycle.

Authors:  Nadine Biedenkopf; Clemens Lier; Stephan Becker
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.